About
Your Exam

 

ACR Accredited PET Facility
PET/CT Detects Recurrent Colorectal Cancer

The Challenge: Detecting Recurrent Disease

PET/CT Helps Identify Patients Who Are Surgical Candidates

“(FDG-PET) alters patient management in that it enables appropriate selection of patients for different treatments based on accurate results regarding the presence and extent of recurrence.” Arulampalam T, et al 3

PET/CT Effectively Identifies Post-operative Recurrence of Colorectal Cancer

Diagnostic Accuracy of PET/CT in Colorectal Cancer

  SENSITIVITY SPECIFICITY NPV PPV
DX/STAGING        
PET 85%2 71%2 99%2 95%2
CT 34%2 92%2 86%2 50%2
RECURRENCE        
PET 94%2 87%2 88%2 93%2
CT 79%2 73%2    


PET/CT Influenced Patient Management

PET/CT Influenced Patient Management

References
1. Steele G, et al. A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Story Group protocol 6584. J Clin Oncol. 1991;9:1105-1112.
2. Gambhir SS, Czernin J, Schwimmer J, Silverman DHS, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med.2001;42(suppl):1S-93S.
3. Arulampalam T, Costa D, Visvikis D, Boulos P, Taylor I, Lee P. The impact of FDG-PET on the management algorithm for recurrent colorectal cancer. Eur J Nucl Med. 2001;28:1758-1765.

Medicare Recognizes the Utility of PET/CT in Colorectal Cancer*

Diagnosis

Staging

Restaging

* New medical evidence supports the use of PET as a useful tool in determining the presence of hepatic/extrahepatic Metastases in the primary staging of colorectal carcinoma, prior to selecting a treatment regimen. Use of PET is also supported in evaluating recurrent colorectal cancer beyond the limited presentation of a rising CEA level where the patient presents with clinical signs or symptoms of recurrence.

** For most solid tumors a tissue diagnosis is usually performed prior to a PET/CT scan.

PET/CT Reveals Extent of Metastases in Patient with Colorectal Cancer

PET Scan

History
A patient with history of colon cancer and post-chemotherapy treatment presents with rising tumor markers (CEA).

CT Findings
CT findings are negative.

PET Findings
PET/CT scan for recurrence shows two active sites of tumor recurrence in the pelvis.

Change in Treatment
Management reevaluated.

© Copyright 2006 - 2012 Washington Imaging Services, LLC All Rights Reserved